A new experimental treatment has been shown to lower bad cholesterol levels, with some reports indicating a reduction of up to 62 percent. This treatment, which is not a statin, may potentially be administered in a single dose, with some outlets suggesting it could provide long-term or even lifelong control of cholesterol levels. The treatment, which involves gene editing, has been reported to safely lower cholesterol levels in early studies.